Press "Enter" to skip to content

FDA warns marketers of products labeled as dietary supplements that contain tianeptine for making unproven claims to treat serious conditions, including opioid use disorder

FDA issued warning letters issued to two companies for the illegal marketing of products labeled as dietary supplements that contain tianeptine.

Original source: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626349.htm

Also Read:   GL Holdings Issues Voluntary Worldwide Recall of Green Lumber Products Due to Presence of Undeclared Tadalafil